Headquarters, R&D and manufacturing in Burlingame, California USA, subsidiary in Peterborough, UK
ABC-AmP, Animal-Free Blocker, AT-Yellow, BLOXALL, DuoLuX, Elite, EndTag, FastTag, Fusion Aid, GC-Red, HYBEX, ImmEdge, ImmPACT, ImmPRESS, ImmPrint, M.O.M., NeuroBiotin, NicKit p.s.o., PHOTOPROBE, PolyBlock, ProFusion, ProtOn, QuantTag, Resolve-It, UltraSNAP, VECTABOND, VectaCell, VectaMount, VECTASHIELD, VECTASHIELD HardSet, VECTASTAIN, Vector, Vector Black, Vector Blue, Vector NovaRED, Vector Red, Vectrex
Carl Hull, CEO
Carl has more than 30 years of experience in life science research and diagnostic companies including Abbott Labs, Ventana Medical Systems, Applied Biosystems and Gen-Probe. Carl took over as CEO of Gen-Probe in 2009 and focused the strategy of the company to take full advantage of its core molecular diagnostics and automation strengths. During Carl’s tenure, the company extended its recognized leadership position in the most rapidly growing segment of diagnostics.
Eric Tardif, President
Eric is an experienced investment banker and director with a focus on medical devices, life science tools and diagnostics. Most recently, he was instrumental in the turnaround and sale of Gen-Probe.
David Weber, VP and Chief Commercial Officer
David has an extensive background in directing the commercial functions of a variety of life science tools companies. Most recently, he served as Executive Vice President and Chief Commercial Officer of Affymetrix, where he helped orchestrate that company’s turnaround and ultimate sale to Thermo Fisher Scientific.
Harjit Kullar, VP, Marketing Harjit is an expert in global product marketing, channel sales and brand development. He has more than 15 years of marketing experience with a range of leading life science tools companies.